ATE308329T1 - Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen - Google Patents

Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen

Info

Publication number: ATE308329T1
Authority: AT; Austria
Prior art keywords: preventing; treating; inhibiting; cellulose sulfate; sulfated polysaccharides
Prior art date: 2000-06-30

Application number

AT01947089T

Other languages

English (en)

Inventor

Thomas C Usher

Robert A Anderson

Lourens J D Zaneveld

Original Assignee

Polydex Pharma

Univ Rush Medical Center

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-30

Filing date

2001-06-29

Publication date

2005-11-15

2001-06-29 Application filed by Polydex Pharma, Univ Rush Medical Center filed Critical Polydex Pharma

2005-11-15 Application granted granted Critical

2005-11-15 Publication of ATE308329T1 publication Critical patent/ATE308329T1/de

Links

150000004676 glycans Chemical class 0.000 title abstract 3
229920001282 polysaccharide Polymers 0.000 title abstract 3
239000005017 polysaccharide Substances 0.000 title abstract 3
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title abstract 2
229920002678 cellulose Polymers 0.000 title abstract 2
239000001913 cellulose Substances 0.000 title abstract 2
241000700605 Viruses Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
230000002401 inhibitory effect Effects 0.000 abstract 4
239000012678 infectious agent Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
206010017533 Fungal infection Diseases 0.000 abstract 1
208000031888 Mycoses Diseases 0.000 abstract 1
241001631646 Papillomaviridae Species 0.000 abstract 1
208000030852 Parasitic disease Diseases 0.000 abstract 1
206010046914 Vaginal infection Diseases 0.000 abstract 1
201000008100 Vaginitis Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000003902 lesion Effects 0.000 abstract 1
230000003211 malignant effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Urology & Nephrology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biotechnology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT01947089T 2000-06-30 2001-06-29 Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen ATE308329T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21532500P	2000-06-30	2000-06-30
PCT/CA2001/000964 WO2002002189A2 (en)	2000-06-30	2001-06-29	Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Publications (1)

Publication Number	Publication Date
ATE308329T1 true ATE308329T1 (de)	2005-11-15

Family

ID=22802531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01947089T ATE308329T1 (de)	2000-06-30	2001-06-29	Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen

Country Status (9)

Country	Link
US (3)	US7078392B2 (de)
EP (1)	EP1296691B1 (de)
AT (1)	ATE308329T1 (de)
AU (1)	AU2001268884A1 (de)
CA (1)	CA2414320C (de)
DE (1)	DE60114620T2 (de)
DK (1)	DK1296691T3 (de)
ES (1)	ES2253395T3 (de)
WO (1)	WO2002002189A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4390259B2 (ja) *	2001-09-06	2009-12-24	有限会社シーバイオン	硫酸多糖類、その製造方法及びそれを有効成分とする物質
US20050009782A1 (en) *	2003-07-09	2005-01-13	Comper Wayne D.	Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
JP2005108098A (ja) *	2003-10-01	2005-04-21	Hitachi Ltd	データｉ／ｏ装置及びデータｉ／ｏ装置の制御方法
BRPI0518557A2 (pt) *	2004-12-17	2008-11-25	Bayer Healthcare Llc	cartucho com sensor de teste descartÁvel
EP1842545A1 (de) *	2006-04-04	2007-10-10	Marinomed Biotechnologie GmbH	Entzündungshemmende Polymer
EP1842546B1 (de) *	2006-04-04	2009-03-11	Marinomed Biotechnologie GmbH	Zellulosesulfat zur Behandlung von Rhinovirus-Infektionen
US20100160254A1 (en) *	2006-04-04	2010-06-24	Marinomed Biotechnologie Gmbh	Cellulose Sulfate for the Treatment of Rhinovirus Infection
EP2116224B1 (de) *	2006-11-27	2016-01-27	JNC Corporation	Kosmetische zusammensetzung
US20080131454A1 (en) *	2006-12-05	2008-06-05	Marinomed Biotechnologie Gmbh	Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
US20080268022A1 (en) *	2007-02-23	2008-10-30	Mccabe R Tyler	Mehtods for treating and preventing ailments caused by human papillomavirus
JP2008266265A (ja) *	2007-04-24	2008-11-06	Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho	抗ウイルス剤
EA018138B1 (ru)	2007-08-24	2013-05-30	Мариномед Биотехнологи Гмбх	Применение йота-каррагенана в качестве противовирусного ингредиента
US20090118352A1 (en) *	2007-11-07	2009-05-07	Esawtech, Ltd.	Broad spectrum microbicidal and spermicidal compositions and methods
US8501214B2 (en) *	2007-11-26	2013-08-06	Modetex Biomedical Materials & Technology Industrial Corp.	Hydrophilic foam and pharmaceutical dosage form employing the same
JP5702526B2 (ja) *	2009-04-30	2015-04-15	Ｅｓファイバービジョンズ株式会社	抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
TWI401096B (zh) *	2009-12-31	2013-07-11		用以治療、管理或預防陰道感染或子宮頸癌的醫藥劑型及其所包含之膠體組成物與親水性泡綿
MD4110C1 (ro) *	2010-10-21	2011-12-31	Валериу РУДИК	Preparat antiherpetiс
FR2989001B1 (fr)	2012-04-06	2017-07-21	Centre Nat Rech Scient	Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
FR2998176B1 (fr) *	2012-11-16	2015-01-16	Univ Blaise Pascal Clermont Ii	Composition de polysaccharide sulfate
WO2014147287A1 (en)	2013-03-21	2014-09-25	Jukka Seppälä	Nanocrystalline cellulose (ncc) as an antiviral compound
WO2016056001A1 (en)	2014-10-06	2016-04-14	Algamed Therapeutics (A.M.T) Ltd	Compositions comprising sulfated polysaccharides and uses thereof
CN105748506B (zh) *	2016-03-03	2018-08-17	青岛海洋生物医药研究院股份有限公司	褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
EP3939597A1 (de) *	2020-07-16	2022-01-19	Marinomed Biotech AG	Antivirale pharmazeutische zusammensetzung enthaltend carrageenan

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1218986A (en)	1982-12-28	1987-03-10	Annamaria Naggi	Process for the depolymerisation and sulfatation of polysaccharides
FR2542616B1 (fr) *	1983-03-17	1987-07-31	Unilever Nv	Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
EP0240098A3 (de) *	1986-04-04	1989-05-10	Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo	Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
DE3851386T2 (de)	1987-07-07	1995-03-30	Ajinomoto Kk	Verwendung von Glycanen als antivirale Verbindungen.
EP0402078A3 (de) *	1989-06-06	1991-07-31	Patrick Daniel Kelly	Sexuelles Gleitmittel mit Zink als antiviralem Wirkstoff
US5208031A (en) *	1989-06-06	1993-05-04	Kelly Patrick D	Sexual lubricants containing zinc as an anti-viral agent
AU1052492A (en)	1991-01-31	1992-08-06	Farmitalia Carlo Erba S.R.L.	Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
CA2146988A1 (en) *	1992-10-13	1994-04-28	Gideon Strassmann	Treatment of cachexia and inhibition of il-6 activity
CA2148607A1 (en) *	1993-09-20	1995-03-30	Ivan Havlik	Antimalarial drug
US6063773A (en) *	1995-09-29	2000-05-16	Polydex Pharmaceuticals Ltd.	Cellulose sulfate for use as antimicrobial and contraceptive agent
US6239182B1 (en)	1995-10-13	2001-05-29	Rush-Presbyterian-St. Lukes Medical Center	Method for preventing sexually transmitted diseases
US5741525A (en)	1995-10-24	1998-04-21	Marshall University Research Corporation	Vaginal pharmaceutical hydrogen peroxide composition
US5955096A (en) *	1996-06-25	1999-09-21	Brown University Research Foundation	Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US5853767A (en)	1997-01-02	1998-12-29	Melman; Steven A.	Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
JPH1180003A (ja) *	1997-09-16	1999-03-23	Yakult Honsha Co Ltd	感染症予防・治療剤

2001
- 2001-06-29 DK DK01947089T patent/DK1296691T3/da active
- 2001-06-29 US US10/312,030 patent/US7078392B2/en not_active Expired - Lifetime
- 2001-06-29 EP EP01947089A patent/EP1296691B1/de not_active Expired - Lifetime
- 2001-06-29 CA CA002414320A patent/CA2414320C/en not_active Expired - Fee Related
- 2001-06-29 AT AT01947089T patent/ATE308329T1/de not_active IP Right Cessation
- 2001-06-29 DE DE60114620T patent/DE60114620T2/de not_active Expired - Fee Related
- 2001-06-29 ES ES01947089T patent/ES2253395T3/es not_active Expired - Lifetime
- 2001-06-29 AU AU2001268884A patent/AU2001268884A1/en not_active Abandoned
- 2001-06-29 WO PCT/CA2001/000964 patent/WO2002002189A2/en not_active Ceased
2004
- 2004-12-01 US US11/001,412 patent/US7226914B2/en not_active Expired - Lifetime
- 2004-12-01 US US11/000,582 patent/US7235536B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60114620D1 (de)	2005-12-08
US7078392B2 (en)	2006-07-18
US7226914B2 (en)	2007-06-05
CA2414320C (en)	2008-04-01
DK1296691T3 (da)	2006-03-20
DE60114620T2 (de)	2006-07-27
ES2253395T3 (es)	2006-06-01
EP1296691A2 (de)	2003-04-02
CA2414320A1 (en)	2002-01-10
EP1296691B1 (de)	2005-11-02
US20050143342A1 (en)	2005-06-30
AU2001268884A1 (en)	2002-01-14
US20050203055A1 (en)	2005-09-15
WO2002002189A2 (en)	2002-01-10
US20030181415A1 (en)	2003-09-25
US7235536B2 (en)	2007-06-26
WO2002002189A3 (en)	2002-09-19

Legal Events

Date

Code

Title

Description

2006-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1296691

Country of ref document: EP

2010-03-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE308329T1 (de)	2005-11-15	Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen
BR0116519B1 (pt)	2012-07-24	cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
FI20020333A0 (fi)	2002-02-20	Metyloidun syklodekstriinin uudet kompleksit
GT200000103A (es)	2001-12-20	Trifluorbutenos nematocidas.
TR200100672T2 (tr)	2001-07-23	Yeni izoksazolinon antibakteriyel ajanları
EP1121135A4 (de)	2005-03-16	Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline
NO20026044D0 (no)	2002-12-16	Behandling av human papillomavirus
BRPI9917862B8 (pt)	2021-05-25	dihidropirimidinas, bem como processo para a preparação e aplicação das mesmas.
DE60124684D1 (de)	2007-01-04	Sulfonamido-substituierte verbrückte bicycloalkylderivative
MXPA04006210A (es)	2005-05-17	Composiciones acuosas que contienen metronidazole.
FR2811996B1 (fr)	2003-08-08	Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
NO20011453L (no)	2001-05-23	Arylsulfonanilid urea
NO983688L (no)	1998-10-12	Serin-protease-inhibitorer
DE69913020D1 (de)	2004-01-08	Transparente Antischuppen-Haarwaschzusammensetzungen
ATE335499T1 (de)	2006-09-15	Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
BRPI0416391A (pt)	2007-01-16	composições de limpeza
ATE517617T1 (de)	2011-08-15	Behandlung von parkinson erkrankung mit kape
BR0106120A (pt)	2002-08-13	Processo para produção de isolongifolanol
DE60204967D1 (de)	2005-08-11	Verwendung von übersulfatierten polysacchariden als hiv-hemmer
ES2128723T3 (es)	1999-05-16	Composicion suavizante de tejidos.
DE60030300D1 (de)	2006-10-05	Topische behandlung zur vorbeugung von augeninfektionen
DE60112768D1 (de)	2005-09-22	Behandlung von entzündlichen erkrankungen
DE60043228D1 (de)	2009-12-10	Herstellungsverfahren von 2-cyanopyridinen
ATE408340T1 (de)	2008-10-15	Prävention und behandlung von mycoplasma- assoziierten krankheiten mit trans-sialidase und/oder neuraminidase
EP1546415A4 (de)	2006-01-11	Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen